• Explore /
  • Poster
  • / Analysis of infections and parameters of humoral immunity in patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with talquetamab (tal) monotherapy in MonumenTAL-1.

Analysis of infections and parameters of humoral immunity in patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with talquetamab (tal) monotherapy in MonumenTAL-1.

Abstract Video & Slides Poster

Authors

Paula Rodríguez-Otero

Paula Rodríguez-Otero

Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain

Paula Rodríguez-Otero , Carolina D. Schinke , Ajai Chari , Brea Lipe , Noa Lavi , Leo Rasche , Deeksha Vishwamitra , Sheri Skerget , Raluca Verona , Xuewen Ma , Sheetal Khedkar , Brandi Hilder , Tara J. Masterson , Michela Campagna , Thomas Renaud , Jaszianne A. Tolbert , Christoph Heuck , Marie-Anne Damiette Smit , Niels W.C.J. van de Donk

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Hematologic Malignancies—Plasma Cell Dyscrasia

Track

Hematologic Malignancies

Sub Track

Multiple Myeloma

Clinical Trial Registration Number

NCT03399799/NCT04634552

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 8020)

DOI

10.1200/JCO.2023.41.16_suppl.8020

Abstract #

8020

Poster Bd #

12

Abstract Disclosures

Similar Posters

First Author: Allison Graeter

First Author: Xuewen Ma

First Author: Gin-Yi Lee

First Author: Cesar Rodriguez Valdes